Well thank you for your views, as you are an erstwhile holder and most here are current holder we beg to differ. We, or many of us, consider that this stock and its patented technology is coming to the end of the development stage. Defence stocks, like medical stocks, are high risk, have long development and certification times so once past these hurdles have significant barriers to entry by competitors. I, and many others therefore believe that the next year and subsequent years will produce solid income returns as various organisations introduce technology based upon MST.
I have I hold I wait.
Add to My Watchlist
What is My Watchlist?